title: [Treatment of non-neurogenic masculine urinary incontinence due to overactive bladder: a review by the LUTS committee of the French Urological Association].
abstract: OBJECTIVE
  To perform an update on the treatment of masculine urinary incontinence due to idiopathic overactive bladder.
  
  
  METHODS
  A systematic review was conducted using PubMed/MEDLINE with the following keywords: "overactive bladder", "male urinary incontinence", "urgency", "antimuscarinic", "onabotulinumtoxinA", "neurostimulation", "cystoplasty".
  
  
  RESULTS
  Antimuscarinic treatments were the first line option for overactive bladder incontinence (decreased incontinence under tolterodine versus placebo respectively -71% vs. -40%, P < 0.05). Their main side effects were dry mouth (16-29.6%) and constipation (4%), which might decrease the observance. In case of failure, neuromostimulation could be prosed with a 67% efficacy rate. Intra-detrusorian injections of onabotulinumtoxinA were an option, however there were still not validated for this indication and their efficacy decreases with time and after repeated injections. The ultimate option in case of refractory major over-activity was cystoplasty, which involves major morbidity for inconstant efficacy.
  
  
  CONCLUSIONS
  The same treatments are available for non-neurologic urinary incontinence by bladder over-activity for men and women: antimuscarinic drugs, neurostimulation, onabotulinumtoxinA. However, only few data is available for masculine population exclusively.
authors: Service d'urologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France. Electronic address: souhil.lebdai@gmail.com.
authors: S
authors: S
authors: Lebdai
authors: Service d'urologie, CHU de Tours, 37044 Tours, France.
authors: O
authors: O
authors: Haillot
authors: Service d'urologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France.
authors: A R
authors: AR
authors: Azzouzi
authors: Service d'urologie, hôpital Bichat-Claude-Bernard, groupe des hôpitaux universitaires Paris-Nord-Val-de-Seine, université Denis-Diderot, Paris-VII, 75018 Paris, France.
authors: A
authors: A
authors: Benchikh
authors: Service d'urologie, CHU Mondor, 75000 Paris, France.
authors: A
authors: A
authors: Campeggi
authors: Service d'urologie, hôpital Tenon, université Paris-VI, 75020 Paris, France.
authors: J-N
authors: JN
authors: Cornu
authors: Service d'urologie, CHU Cochin, 75014 Paris, France.
authors: N B
authors: NB
authors: Delongchamps
authors: Service d'urologie, clinique Turin, 75008 Paris, France.
authors: O
authors: O
authors: Dumonceau
authors: Clinique mutualiste Beausoleil, 34070 Montpellier, France.
authors: A
authors: A
authors: Faix
authors: Service d'urologie, centre hospitalier Aix-en-Provence, 13616 Aix-en-Provence, France.
authors: M
authors: M
authors: Fourmarier
authors: Service d'urologie, hôpital Tenon, université Paris-VI, 75020 Paris, France.
authors: B
authors: B
authors: Lukacs
authors: Service d'urologie, hôpital Pontchaillou, CHU de Rennes, 35000 Rennes, France.
authors: R
authors: R
authors: Mathieu
authors: Service d'urologie, clinique Pasteur, 31300 Toulouse, France.
authors: V
authors: V
authors: Misrai
authors: Service d'urologie, université Bordeaux Segalen, CHU de Bordeaux, 33076 Bordeaux, France.
authors: G
authors: G
authors: Robert
authors: Service d'urologie, CHU Mondor, 75000 Paris, France.
authors: A
authors: A
authors: de La Taille
authors: Service de chirurgie urologique, CHU de Limoges, 87042 Limoges, France.
authors: A
authors: A
authors: Descazeaud
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D062187:Spinal Cord Stimulation; D053201:Urinary Bladder, Overactive / Q000150:complications*; D014549:Urinary Incontinence / Q000209:etiology* / Q000628:therapy*
chemical_list: D065087:Acetylcholine Release Inhibitors; D018680:Cholinergic Antagonists; D019274:Botulinum Toxins, Type A
keywords: Anticholinergiques; Antimuscarinic; Cystoplasty; Entérocystoplastie; Hyperactivité vésicale; Incontinence urinaire masculine; Male urinary incontinence; Neurostimulation; Neurostimultion; OnabotulinumtoxinA; Overactive bladder; Urgency; Urgenturies